Savant Capital LLC Sells 2,520 Shares of Lincoln National Co. (NYSE:LNC)

Savant Capital LLC lowered its position in shares of Lincoln National Co. (NYSE:LNC) by 7.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,123 shares of the financial services provider’s stock after selling 2,520 shares during the quarter. Savant Capital LLC’s holdings in Lincoln National were worth $955,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Blue Trust Inc. lifted its stake in shares of Lincoln National by 535.5% during the 3rd quarter. Blue Trust Inc. now owns 1,074 shares of the financial services provider’s stock valued at $33,000 after buying an additional 905 shares in the last quarter. Larson Financial Group LLC raised its holdings in Lincoln National by 95.3% during the third quarter. Larson Financial Group LLC now owns 1,086 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 530 shares during the period. Eastern Bank purchased a new position in shares of Lincoln National in the third quarter valued at about $40,000. Meeder Asset Management Inc. bought a new position in shares of Lincoln National in the third quarter worth about $48,000. Finally, Crews Bank & Trust purchased a new stake in shares of Lincoln National during the fourth quarter worth about $51,000. 72.81% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on LNC. Barclays boosted their target price on shares of Lincoln National from $36.00 to $38.00 and gave the stock an “equal weight” rating in a report on Friday, February 7th. TD Cowen boosted their price target on shares of Lincoln National from $34.00 to $37.00 and gave the stock a “hold” rating in a research note on Wednesday, November 27th. Wells Fargo & Company cut their price objective on Lincoln National from $29.00 to $28.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 14th. StockNews.com upgraded Lincoln National from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Keefe, Bruyette & Woods raised their price target on Lincoln National from $37.00 to $40.00 and gave the company a “market perform” rating in a report on Wednesday. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $35.40.

Lincoln National Stock Performance

NYSE:LNC opened at $39.09 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.27 and a current ratio of 0.27. The stock’s fifty day moving average is $33.32 and its 200 day moving average is $32.70. The firm has a market capitalization of $6.66 billion, a PE ratio of 2.13, a PEG ratio of 0.28 and a beta of 1.79. Lincoln National Co. has a fifty-two week low of $25.60 and a fifty-two week high of $39.85.

Lincoln National (NYSE:LNC) last released its earnings results on Thursday, February 6th. The financial services provider reported $1.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.04. Lincoln National had a net margin of 17.76% and a return on equity of 18.47%. On average, sell-side analysts anticipate that Lincoln National Co. will post 7.63 earnings per share for the current year.

Lincoln National Company Profile

Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates in four segments: Life Insurance, Annuities, Group Protection, and Retirement Plan Services. The Life Insurance segment provides life insurance products, including term insurance, universal life insurance (UL), indexed universal life insurance, variable universal life insurance (VUL), linked-benefit UL and VUL products, and critical illness and long-term care riders.